Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient
نویسندگان
چکیده
منابع مشابه
Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient
BACKGROUND Nivolumab is an anti-PD-1 immune checkpoint inhibitor that was recently developed for cancer immunotherapy. In the clinical trials of nivolumab, its adverse effects were reported to be less likely than those of conventional anti-cancer agents; however, after practical clinical distribution, it has come to be known that nivolumab induces various immune-related adverse events. CASE REP...
متن کاملNivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer
BACKGROUND Advances in cancer immunotherapy have generated encouraging results in multiple malignancies refractory to standard chemotherapies. As the use of immune checkpoint inhibitors (ICI) proliferates, the incidence of autoimmune side effects associated with these agents, termed immune related adverse events (irAE), is expected to increase. The frequency of significant irAE in ICI treated p...
متن کاملParaneoplastic granulocytosis in an advanced lung cancer patient.
Paraneoplastic syndromes (PNPs) refer to cancer-associated signs and symptoms arising in organs and tissues that are remote from the cancer and unrelated to metastasis. Currently the best described PNPs are attributed to tumor secretion of functional peptides and hormones or immune cross-reactivity between tumor and normal host tissues. Paraneoplastic hematologic syndromes are observed more rar...
متن کاملConcurrence of nivolumab‐induced interstitial lung disease and cancer invasion
Nivolumab improves overall survival rates of patients with advanced or recurrent non-small-cell lung cancer (NSCLC). Among immune-related adverse events caused by nivolumab, interstitial lung disease (ILD) is a clinically serious and potentially life-threatening toxicity, for which appropriate treatment is needed immediately. However, ILD is sometimes difficult to distinguish from invasive lung...
متن کاملNivolumab for advanced non-small cell lung cancer: an immunologically-mediated tumor checkout.
Department of Preventive Medicine Interdisciplinary, Iasi, Romania; Marius Nasta Institute, Bucuresti, Romania, Faculty of Medicine, University of Medicine Oradea, Bucuresti, Romania Correspondence to: Sabina Antoniu, MD, PhD. Lecturer, Department of Preventive Medicine Interdisciplinary, Medicine-Palliative Care Nursing, University of Medicine and Pharmacy, “Gr.T.Popa” Iasi, Romania, 16 Univer...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Case Reports
سال: 2016
ISSN: 1941-5923
DOI: 10.12659/ajcr.900941